David Watson

Insider Reports History

Location
Crestwood, KY
Signature
David Watson
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Watson:

Company Role Class Num Shares Value Price $ Report Date Ownership
Apellis Pharmaceuticals, Inc. General Counsel Common Stock 144,517 $3,630,281 $25.12 28 Jan 2026 Direct
Apellis Pharmaceuticals, Inc. General Counsel Stock Option (Right to Buy) 14,000 $1,599,675 $19.39 07 Jan 2026 Direct
Apellis Pharmaceuticals, Inc. General Counsel Common Stock 50,136 $1,259,421 $25.12 28 Jan 2026 Indirect Owner (The David O. Watson Irrevocable Trust of 2023)
Apellis Pharmaceuticals, Inc. General Counsel Common Stock 10,000 $251,201 $25.12 28 Jan 2026 Indirect Owner (Custodial Account for minor children)
Apellis Pharmaceuticals, Inc. General Counsel Common Stock 0 $0 $25.12 28 Jan 2026 Indirect Owner (The Watson Education Trust)

Insider Reports Filed by David Watson

Symbol Company Period Transactions Value $ Form Type Role Filing Time
APLS Apellis Pharmaceuticals, Inc. 28 Jan 2026 1 $0 4 General Counsel 30 Jan 2026, 16:06
APLS Apellis Pharmaceuticals, Inc. 22 Jan 2026 1 -$170,467 4 General Counsel 23 Jan 2026, 16:05
APLS Apellis Pharmaceuticals, Inc. 20 Jan 2026 1 -$48,987 4 General Counsel 21 Jan 2026, 16:08
APLS Apellis Pharmaceuticals, Inc. 13 Jan 2026 1 -$128,242 4 General Counsel 15 Jan 2026, 16:28
APLS Apellis Pharmaceuticals, Inc. 07 Jan 2026 2 +$13,276 4 General Counsel 09 Jan 2026, 18:48
APLS Apellis Pharmaceuticals, Inc. 16 Dec 2025 1 -$122,450 4 General Counsel 18 Dec 2025, 16:06
APLS Apellis Pharmaceuticals, Inc. 17 Nov 2025 1 -$100,300 4 General Counsel 18 Nov 2025, 10:05
APLS Apellis Pharmaceuticals, Inc. 16 Oct 2025 1 -$126,100 4 General Counsel 17 Oct 2025, 16:15
APLS Apellis Pharmaceuticals, Inc. 16 Sep 2025 1 -$121,700 4 General Counsel 18 Sep 2025, 16:01
APLS Apellis Pharmaceuticals, Inc. 10 Sep 2025 1 -$523,400 4 General Counsel 12 Sep 2025, 16:01
APLS Apellis Pharmaceuticals, Inc. 18 Aug 2025 1 -$139,000 4 General Counsel 19 Aug 2025, 16:40
APLS Apellis Pharmaceuticals, Inc. 16 Jul 2025 1 -$97,750 4 General Counsel 18 Jul 2025, 16:00
APLS Apellis Pharmaceuticals, Inc. 16 Jun 2025 1 -$93,850 4 General Counsel 18 Jun 2025, 08:49
APLS Apellis Pharmaceuticals, Inc. 09 Jun 2025 1 +$1,599,675 4 General Counsel 11 Jun 2025, 16:25
APLS Apellis Pharmaceuticals, Inc. 04 Mar 2025 3 -$139,789 4 General Counsel 06 Mar 2025, 17:17
APLS Apellis Pharmaceuticals, Inc. 29 Jan 2025 1 -$20,519 4 General Counsel 30 Jan 2025, 12:20
APLS Apellis Pharmaceuticals, Inc. 22 Jan 2025 1 -$101,104 4 General Counsel 23 Jan 2025, 15:41
APLS Apellis Pharmaceuticals, Inc. 17 Jan 2025 2 -$65,938 4 General Counsel 21 Jan 2025, 16:14
APLS Apellis Pharmaceuticals, Inc. 13 Jan 2025 1 -$142,506 4 General Counsel 14 Jan 2025, 16:30
APLS Apellis Pharmaceuticals, Inc. 11 Dec 2024 1 -$171,175 4 General Counsel 13 Dec 2024, 16:15
APLS Apellis Pharmaceuticals, Inc. 27 Sep 2024 2 $0 4 General Counsel 30 Sep 2024, 16:15
APLS Apellis Pharmaceuticals, Inc. 06 Mar 2024 2 +$52,104 4 General Counsel 08 Mar 2024, 07:45
APLS Apellis Pharmaceuticals, Inc. 12 Feb 2024 1 -$52,926 4 General Counsel 13 Feb 2024, 17:06
APLS Apellis Pharmaceuticals, Inc. 29 Jan 2024 1 -$58,109 4 General Counsel 31 Jan 2024, 16:38
APLS Apellis Pharmaceuticals, Inc. 22 Jan 2024 1 -$271,943 4 General Counsel 23 Jan 2024, 18:17
APLS Apellis Pharmaceuticals, Inc. 16 Jan 2024 3 +$2,006,269 4 General Counsel 17 Jan 2024, 16:38
APLS Apellis Pharmaceuticals, Inc. 19 Dec 2023 4 -$113,988 4 General Counsel 20 Dec 2023, 16:18
APLS Apellis Pharmaceuticals, Inc. 03 Jul 2023 1 -$765,730 4 General Counsel 06 Jul 2023, 16:20
APLS Apellis Pharmaceuticals, Inc. 28 Jun 2023 2 $0 4 General Counsel 29 Jun 2023, 16:13
APLS Apellis Pharmaceuticals, Inc. 21 Apr 2023 2 $0 4 General Counsel 24 Apr 2023, 16:20
APLS Apellis Pharmaceuticals, Inc. 21 Feb 2023 3 -$48,262 4 General Counsel 22 Feb 2023, 05:42
APLS Apellis Pharmaceuticals, Inc. 10 Feb 2023 1 -$27,244 4 General Counsel 14 Feb 2023, 16:29
APLS Apellis Pharmaceuticals, Inc. 27 Jan 2023 1 -$29,076 4 General Counsel 30 Jan 2023, 16:19
APLS Apellis Pharmaceuticals, Inc. 20 Jan 2023 1 -$105,870 4 General Counsel 24 Jan 2023, 16:33
APLS Apellis Pharmaceuticals, Inc. 12 Jan 2023 3 +$1,985,703 4 General Counsel 17 Jan 2023, 18:46
APLS Apellis Pharmaceuticals, Inc. 22 Jun 2022 1 -$445,140 4 General Counsel 23 Jun 2022, 16:22
APLS Apellis Pharmaceuticals, Inc. 21 Apr 2022 3 -$250,000 4 General Counsel 27 Apr 2022, 16:39
APLS Apellis Pharmaceuticals, Inc. 10 Feb 2022 1 -$23,136 4 General Counsel 14 Feb 2022, 17:36
APLS Apellis Pharmaceuticals, Inc. 28 Jan 2022 1 -$25,084 4 General Counsel 01 Feb 2022, 17:03
APLS Apellis Pharmaceuticals, Inc. 21 Jan 2022 2 $0 4 General Counsel 25 Jan 2022, 15:49
APLS Apellis Pharmaceuticals, Inc. 31 Dec 2021 1 $0 5 General Counsel 10 Feb 2022, 15:51
APLS Apellis Pharmaceuticals, Inc. 27 Dec 2021 1 -$58,200 4 General Counsel 28 Dec 2021, 16:38
APLS Apellis Pharmaceuticals, Inc. 22 Dec 2021 11 -$215,698 4 General Counsel 23 Dec 2021, 15:58
APLS Apellis Pharmaceuticals, Inc. 10 Sep 2021 2 +$4,112 4 General Counsel 13 Sep 2021, 16:08
APLS Apellis Pharmaceuticals, Inc. 21 Jun 2021 2 +$2,108 4 General Counsel 22 Jun 2021, 16:02
APLS Apellis Pharmaceuticals, Inc. 28 May 2021 2 +$2,108 4 General Counsel 01 Jun 2021, 16:53